Xuezheng Sun1, Hazel B Nichols2,3, Whitney Robinson2, Mark E Sherman4,5, Andrew F Olshan2,3, Melissa A Troester2,3. 1. Department of Epidemiology, CB 7435, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. amysun@email.unc.edu. 2. Department of Epidemiology, CB 7435, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. 3. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. 4. Hormonal and Reproductive Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. 5. Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD, USA.
Abstract
PURPOSE: Adiposity has been linked with increased breast cancer risk and mortality. It is established that etiologic associations for adiposity vary by tumor subtype, but the influence of adiposity on subtype-specific survival is unknown. METHODS: Study participants were 1,109 invasive breast cancer participants in the population-based Carolina Breast Cancer Study, diagnosed between 1993 and 2001, and with tissue blocks available for immunohistochemical subtyping. General and central adiposities were assessed by body mass index (BMI) and waist-to-hip ratio (WHR), respectively, based on in-person measurements after diagnosis. Vital status as of 2011 was determined using the National Death Index (median follow-up = 13.5 years). Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for breast cancer (BC)-specific and all-cause mortalities. RESULTS: Among all patients, high WHR (≥0.84), but not BMI, was associated with all-cause mortality (adjusted HR 1.50, 95% CI 1.11-2.05, <0.77 as reference). No significant association between adiposity and BC-specific mortality was detected, although there was a suggestion of increased mortality risk among high-BMI (≥30 kg/m(2)) patients with basal-like tumors (adjusted HR 2.44, 95% CI 0.97-6.12, <25 kg/m(2) as reference). Quantitative differences in all-cause mortality were observed by subtype, with BMI associated with basal-like mortality and WHR associated with luminal mortality. The associations were attenuated by tumor characteristics. CONCLUSIONS: Our study confirms the association of adiposity and unfavorable overall survival in breast cancer patients and suggests that this association may vary by intrinsic subtype and adiposity measure.
PURPOSE: Adiposity has been linked with increased breast cancer risk and mortality. It is established that etiologic associations for adiposity vary by tumor subtype, but the influence of adiposity on subtype-specific survival is unknown. METHODS: Study participants were 1,109 invasive breast cancerparticipants in the population-based Carolina Breast Cancer Study, diagnosed between 1993 and 2001, and with tissue blocks available for immunohistochemical subtyping. General and central adiposities were assessed by body mass index (BMI) and waist-to-hip ratio (WHR), respectively, based on in-person measurements after diagnosis. Vital status as of 2011 was determined using the National Death Index (median follow-up = 13.5 years). Cox proportional hazards models were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for breast cancer (BC)-specific and all-cause mortalities. RESULTS: Among all patients, high WHR (≥0.84), but not BMI, was associated with all-cause mortality (adjusted HR 1.50, 95% CI 1.11-2.05, <0.77 as reference). No significant association between adiposity and BC-specific mortality was detected, although there was a suggestion of increased mortality risk among high-BMI (≥30 kg/m(2)) patients with basal-like tumors (adjusted HR 2.44, 95% CI 0.97-6.12, <25 kg/m(2) as reference). Quantitative differences in all-cause mortality were observed by subtype, with BMI associated with basal-like mortality and WHR associated with luminal mortality. The associations were attenuated by tumor characteristics. CONCLUSIONS: Our study confirms the association of adiposity and unfavorable overall survival in breast cancerpatients and suggests that this association may vary by intrinsic subtype and adiposity measure.
Entities:
Keywords:
Adiposity; Body mass index; Breast cancer subtype; Mortality; Obesity; Survival; Waist hip ratio
Authors: Mia M Gaudet; Michael F Press; Robert W Haile; Charles F Lynch; Sally L Glaser; Joellen Schildkraut; Marilie D Gammon; W Douglas Thompson; Jonine L Bernstein Journal: Breast Cancer Res Treat Date: 2011-06-11 Impact factor: 4.872
Authors: William F Anderson; Philip S Rosenberg; Aleix Prat; Charles M Perou; Mark E Sherman Journal: J Natl Cancer Inst Date: 2014-08-12 Impact factor: 13.506
Authors: Aleix Prat; Maggie Chon U Cheang; Miguel Martín; Joel S Parker; Eva Carrasco; Rosalía Caballero; Scott Tyldesley; Karen Gelmon; Philip S Bernard; Torsten O Nielsen; Charles M Perou Journal: J Clin Oncol Date: 2012-12-10 Impact factor: 44.544
Authors: C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein Journal: Nature Date: 2000-08-17 Impact factor: 49.962
Authors: Ronny Mowad; Quyen D Chu; Benjamin D L Li; Gary V Burton; Frederico L Ampil; Roger H Kim Journal: J Surg Res Date: 2013-06-02 Impact factor: 2.192
Authors: Marilyn L Kwan; Candyce H Kroenke; Carol Sweeney; Philip S Bernard; Erin K Weltzien; Adrienne Castillo; Rachel E Factor; Kaylynn S Maxfield; Inge J Stijleman; Lawrence H Kushi; Charles P Quesenberry; Laurel A Habel; Bette J Caan Journal: BMC Cancer Date: 2015-04-14 Impact factor: 4.430
Authors: Ying L Liu; Anurag Saraf; Benjamin Catanese; Shing M Lee; Yuan Zhang; Eileen P Connolly; Kevin Kalinsky Journal: Breast Cancer Res Treat Date: 2017-09-25 Impact factor: 4.872
Authors: Elizabeth M Cespedes Feliciano; Marilyn L Kwan; Lawrence H Kushi; Wendy Y Chen; Erin K Weltzien; Adrienne L Castillo; Carol Sweeney; Philip S Bernard; Bette J Caan Journal: Cancer Date: 2017-03-13 Impact factor: 6.860
Authors: Elizabeth M Cespedes Feliciano; Marilyn L Kwan; Lawrence H Kushi; Erin K Weltzien; Adrienne L Castillo; Bette J Caan Journal: Breast Cancer Res Treat Date: 2017-02-07 Impact factor: 4.872
Authors: Marc A Emerson; Katherine E Reeder-Hayes; Heather J Tipaldos; Mary E Bell; Marina R Sweeney; Lisa A Carey; H Shelton Earp; Andrew F Olshan; Melissa A Troester Journal: Curr Breast Cancer Rep Date: 2020-05-14
Authors: Xuezheng Sun; Delisha A Stewart; Rupninder Sandhu; Erin L Kirk; Wimal W Pathmasiri; Susan L McRitchie; Robert F Clark; Melissa A Troester; Susan J Sumner Journal: PLoS One Date: 2018-04-18 Impact factor: 3.240